Advertisement

Topics

M&As this week: Intermediate Capital Group, Novartis

19:00 EDT 7 Jun 2018 | Pharmaceutical Technology

Intermediate Capital Group has completed the acquisition of SuanFarma from ProA Capital, a private equity firm based in Spain. Based...
Read More...

The post M&As this week: Intermediate Capital Group, Novartis appeared first on Pharmaceutical Technology.

Original Article: M&As this week: Intermediate Capital Group, Novartis

NEXT ARTICLE

More From BioPortfolio on "M&As this week: Intermediate Capital Group, Novartis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...